Focus on new growth segments, resource optimisation and massive restructuring herald a new era of ‘healthcare preparedness’ post-COVID-19.
Stakeholders across the biosimilars value chain need to collaborate and deliver a digitised patient-centric solution to address patients’ needs.
COVID-19 has taught some harsh lessons that will change healthcare delivery forever.
Measures that healthcare providers must take today to be ready for the challenges of tomorrow.
This webinar sheds light on the ongoing business and legal impact of the coronavirus on organisations in the UAE.
Public health authorities can take five sets of actions that build on important lessons from COVID-19.
Insight into the UAE’s laws and guidelines with respect to the importation of pharmaceuticals and medical devices.
Healthcare providers are using ultrasound systems for the triage, monitoring, and diagnosis of COVID-19 patients.
The ventilator market this year will be worth US$4.6bn.